NewsRx

Search our medical news database

7TM Pharma

Obesity drug developer adds new member to its investor group

Published in Lab Business Week, September 25th, 2005

7TM Pharma has expanded its investor base by including Johnson & Johnson Development Corporation (JJDC) as investor in the company and discussed its clinical progress.

The size of the investment is not disclosed.

The proceeds from JJDC's investment combined with investments from current investors as well as revenues from collaborative agreements will be used to advance 7TM Pharma's development and discovery programs with a focus on metabolic disorders.

"We are very pleased to include JJDC as investor in 7TM Pharma," said Mette Kirstine Agger, CEO of 7TM Pharma. "We have a strong investor group that is supporting us continuously...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Lab Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook